Clinicopathological characteristics of atypical cystic duct (ACD) of the breast: Assessment of ACD as a precancerous lesion

Pathology International

Volumn 50, Issue 10, 2000, Pages 793-800

  Kusama, Ritsu ^a   Fujimori, Minoru ^a   Matsuyama, Ikuo ^b   Fu, Li ^b   Ishii, Keiko ^b   Hama, Yoshihisa ^a   Asanuma, Kazuhiko ^a   Shingu, Kiyoshi ^a   Kobayashi, Shinya ^a   Tsuchiya, Shin Ichi ^b  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Nagano Cancer Detection Center   (Japan)

Author keywords

Atypical cystic duct; Breast neoplasm; Precancerous lesion

Indexed keywords

ESTROGEN RECEPTOR; KI 67 ANTIGEN; ONCOPROTEIN C ERB 2; PROGESTERONE RECEPTOR; PROTEIN P53; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST TUMOR; CANCER CYTODIAGNOSIS; CONTROLLED STUDY; FEMALE; FIBROCYSTIC BREAST DISEASE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LABELING INDEX; ONCOGENE C ERB; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM PROTEINS; PRECANCEROUS CONDITIONS; PREMENOPAUSE; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TUMOR MARKERS, BIOLOGICAL;

EID: 0033695021     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1827.2000.01121.x     Document Type: Article

References (25)

1. Atypical Hyperplastic lesions of the female breast
2. Cyclin D1 associated proteins mammary ductal carcinoma in situ and atypical ductal hyperplasia
3. Nusensho no Kiso to Rinsho
4. Atypical ductal hyperplasia, atypical lobular hyperplasia and interpretation of a new borderline lesion
5. Clinicopathological features and incidence of invasive lobular carcinoma in Japanese women
6. The World Health Organization histopathological typing of breast tumors
7. Immunohistochemical study on overexpression of c-erbB2 protein in human breast cancer: Its correlation with gene amplification and long-term survival of patients
8. Atypical cystic lobules: An early stage in the formation of low-grade ductal carcinoma in situ
9. p53 mutations in human cancers
10. The p53 tumor suppressor gene
11. Immunohistochemical expression of the mutant p53 protein and nuclear DNA content during the transition from benign to malignant breast disease
12. Expression of p53 protein in benign epithelial hyperplasia, atypical ductal hyperplasia, non-invasive and invasive mammary carcinoma: An immunohistochemical study
13. p53 protein expression in mammary ductal carcinoma in situ
14. Histologic grade and p53 immunoreaction as indicators of early recurrence of node-negative breast cancer
15. p53 mutations in mammary ductal carcinoma in situ but not in epithelial hyperplasias
16. Immunohistochemical evaluation of c-erbB2 oncogene expression in ductal carcinoma in situ and atypical ductal hyperplasia of the breast
17. Immunohistochemical studies of early breast cancer evolution
18. Immunohistochemical distribution of c-erbB2 in infiltrating and in situ breast cancer
19. Pathological characterization of atypical ductal hyperplasia of the breast
20. Cystic hypersecretory duct carcinoma of the breast
21. Mucocele-like tumors of the breast
22. Mucocelelike tumor of the breast associated with atypical ductal hyperplasia or mucinous carcinoma
23. A mucocele-like tumor of the breast associated with both atypical ductal hyperplasia and mucoid carcinoma
24. Mucinous lesions of the breast. A pathological continuum
25. Loss of hetrozygosity in normal tissue adjacent to breast carcinomas